Mitogen‐activated protein kinases as therapeutic targets for asthma

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Pharmacology and Therapeutics

• Publication date

  2017-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.pharmthera.2017.02.024PMID 28223227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and Safety of Benralizumab, a Monoclonal Antibody against IL-5Rα, in Uncontrolled Eosinophilic Asthma

  2016cited by this paper
• Role of the extracellular signal-regulated kinase 1/2 signaling pathway in the process of thrombin-promoting airway remodeling in ovalbumin-allergic rats

  2015cited by this paper
• Multi-kinase inhibitors.

  2015cited by this paper
• Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects

  2015cited by this paper
• TNF-α Mediates PKCδ/JNK1/2/c-Jun-Dependent Monocyte Adhesion via ICAM-1 Induction in Human Retinal Pigment Epithelial Cells

  2015cited by this paper
• SP600125 promotes resolution of allergic airway inflammation via TLR9 in an OVA-induced murine acute asthma model.

  2015influential reference
• p38 MAPK: a potential target of chronic pain.

  2014cited by this paper
• Impact of ozone exposure on the response to glucocorticoid in a mouse model of asthma: involvements of p38 MAPK and MKP-1

  2014cited by this paper
• Therapeutic Potential of p38 MAP Kinase Inhibition in the Management of Cardiovascular Disease

  2014cited by this paper
• Corticosteroid insensitive alveolar macrophages from asthma patients; synergistic interaction with a p38 mitogen-activated protein kinase (MAPK) inhibitor.

  2014cited by this paper
• Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial.

  2014cited by this paper
• Mitogen-Activated Protein Kinases as Therapeutic Targets for Rheumatoid Arthritis

  2013cited by this paper
• Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial

  2013cited by this paper
• Activation of p38 mitogen‐activated protein kinase in ovalbumin and ozone‐induced mouse model of asthma

  2013cited by this paper
• Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease.

  2013cited by this paper
• A meta-analysis of the role of p38 mitogen-activated protein kinase inhibitors in patients with active rheumatoid arthritis

  2013cited by this paper
• Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis

  2013cited by this paper
• Inhibition of p38 MAPK Reduces Expression of Vascular Endothelial Growth Factor in Allergic Airway Disease

  2012influential reference
• An Oral Inhibitor of p38 MAP Kinase Reduces Plasma Fibrinogen in Patients With Chronic Obstructive Pulmonary Disease

  2012influential reference
• Targeting cancer with small-molecular-weight kinase inhibitors.

  2012cited by this paper
• Restoration of Corticosteroid Sensitivity by p38 Mitogen Activated Protein Kinase Inhibition in Peripheral Blood Mononuclear Cells from Severe Asthma

  2012cited by this paper
• Inhibition of p38 Mitogen-Activated Protein Kinase Improves Nitric Oxide–Mediated Vasodilatation and Reduces Inflammation in Hypercholesterolemia

  2011cited by this paper
• Design and synthesis of inhaled p38 inhibitors for the treatment of chronic obstructive pulmonary disease.

  2011cited by this paper
• Inhibition of p 38 Mitogen-Activated Protein Kinase Improves Nitric Oxide

  2011cited by this paper
• Remodeling in asthma.

  2011cited by this paper
• A novel dithiol amide CB3 attenuates allergic airway disease through negative regulation of p38 mitogen-activated protein kinase.

  2011cited by this paper
• p38 Mitogen-Activated Protein Kinase-γ Inhibition by Long-Acting β2 Adrenergic Agonists Reversed Steroid Insensitivity in Severe Asthma

  2011cited by this paper
• Inhibition of p38 Mitogen-Activated Protein Kinase Reduces Inflammation After Coronary Vascular Injury in Humans

  2010cited by this paper
• Ozone exposure enhances mast-cell inflammation in asthmatic airways despite inhaled corticosteroid therapy

  2010cited by this paper
• Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids

  2010cited by this paper
• A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease

  2010cited by this paper
• Masitinib, a c‐kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid‐dependent asthmatics

  2009cited by this paper
• Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

  2009cited by this paper
• Suppression of GATA-3 Nuclear Import and Phosphorylation: A Novel Mechanism of Corticosteroid Action in Allergic Disease

  2009influential reference
• Remodeling in asthma.

  2009cited by this paper
• Successful structure-based design of recent p38 MAP kinase inhibitors.

  2009cited by this paper
• Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma

  2009cited by this paper
• Glucocorticoid resistance in inflammatory diseases.

  2009cited by this paper
• “Go upstream, young man”: lessons learned from the p38 saga

  2009cited by this paper
• Selective p38α mitogen-activated protein kinase inhibitor attenuates lung inflammation and fibrosis in IL-13 transgenic mouse model of asthma

  2008cited by this paper
• Biologics in asthma: difficulties and drawbacks

  2008cited by this paper
• Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases

  2008cited by this paper
• The kinase p38α serves cell type–specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression

  2008cited by this paper
• Dexamethasone-induced expression of endothelial mitogen-activated protein kinase phosphatase-1 involves activation of the transcription factors activator protein-1 and 3',5'-cyclic adenosine 5'-monophosphate response element-binding protein and the generation of reactive oxygen species.

  2008cited by this paper
• Dual specificity phosphatase 1 knockout mice show enhanced susceptibility to anaphylaxis but are sensitive to glucocorticoids.

  2007cited by this paper
• [Effect of extracellular-signal regulated kinase 1/2 specific repressor PD98059 on murine lymphocyte proliferation].

  2007cited by this paper
• MAPK phosphatase‐1 represents a novel anti‐inflammatory target of glucocorticoids in the human endothelium

  2007influential reference
• TGF-beta1 stimulates human AT1 receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and PI3K signaling pathways.

  2007cited by this paper
• Extracellular signal-regulated kinase activation in airway smooth muscle cell proliferation in chronic asthmatic rats.

  2007cited by this paper
• Importance of p38 mitogen-activated protein kinase pathway in allergic airway remodelling and bronchial hyperresponsiveness.

  2006cited by this paper
• Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1

  2006cited by this paper
• CXCL12 and C5a trigger cell migration via a PAK1/2-p38alpha MAPK-MAPKAP-K2-HSP27 pathway.

  2006cited by this paper
• Potential role of c-Jun NH2-terminal kinase in allergic airway inflammation and remodelling: effects of SP600125.

  2005influential reference
• Inhaled p38alpha mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice.

  2005cited by this paper
• Pyridinyl imidazoles inhibit IL-1 and TNF production at the protein level

  2005influential reference
• CGH2466, a combined adenosine receptor antagonist, p38 mitogen‐activated protein kinase and phosphodiesterase type 4 inhibitor with potent in vitro and in vivo anti‐inflammatory activities

  2005influential reference
• Generation and Characterization of p38β (MAPK11) Gene-Targeted Mice

  2005cited by this paper
• Activation and signaling of the p38 MAP kinase pathway

  2005cited by this paper
• Inhibitors of mitogen-activated protein kinases differentially regulate costimulated T cell cytokine production and mouse airway eosinophilia

  2005influential reference
• Regulation of TGF-beta 1-induced connective tissue growth factor expression in airway smooth muscle cells.

  2005cited by this paper
• The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.

  2005cited by this paper
• Additive Effect of Diesel Exhaust Particulates and Ozone on Airway Hyperresponsiveness and Inflammation in a Mouse Model of Asthma

  2005cited by this paper
• Targeting kinases in asthma

  2005cited by this paper
• Anti-Inflammatory Effects of Mitogen-Activated Protein Kinase Kinase Inhibitor U0126 in an Asthma Mouse Model1

  2004cited by this paper
• Mitogen‐activated protein kinase signalling pathways in IL‐1β‐dependent rat airway smooth muscle proliferation

  2004cited by this paper
• Interleukin‐6 is a direct mediator of T cell migration

  2004cited by this paper
• Vascular endothelial growth factor-induced secretion of fibronectin is ERK dependent.

  2004cited by this paper
• Steroid resistance in asthma: a major problem requiring novel solutions or a non-issue?

  2004cited by this paper
• p38α Mitogen-Activated Protein Kinase Inhibition Improves Cardiac Function and Reduces Myocardial Damage in Isoproterenol-Induced Acute Myocardial Injury in Rats

  2004cited by this paper
• Increased thrombin activity after allergen challenge: a potential link to airway remodeling?

  2004cited by this paper
• Inhibition of early airway neutrophilia does not affect development of airway hyperresponsiveness.

  2004influential reference
• The quantity and duration of FcRgamma signals determine mast cell degranulation and survival.

  2004cited by this paper
• Regulation of TGF-β1-induced connective tissue growth factor expression in airway smooth muscle cells

  2004cited by this paper
• Effect of an inhibitor of Jun N‐terminal protein kinase, SP600125, in single allergen challenge in sensitized rats

  2004influential reference
• Antinociceptive action of a p38&agr; MAPK inhibitor, SD‐282, in a diabetic neuropathy model

  2004influential reference
• Human lung fibroblasts express interleukin-6 in response to signaling after mast cell contact.

  2004cited by this paper
• Mitogen-activated protein kinases: A new therapeutic target in cardiac pathology

  2003cited by this paper
• Theophylline: new perspectives for an old drug.

  2003cited by this paper
• Oncostatin M Regulates Eotaxin Expression in Fibroblasts and Eosinophilic Inflammation in C57BL/6 Mice1

  2003cited by this paper
• Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease.

  2003cited by this paper
• IL-13-induced changes in the goblet cell density of human bronchial epithelial cell cultures: MAP kinase and phosphatidylinositol 3-kinase regulation.

  2003cited by this paper
• Modulation by cAMP of IL‐1β‐induced eotaxin and MCP‐1 expression and release in human airway smooth muscle cells

  2003cited by this paper
• New insights into the pathogenesis of asthma.

  2003cited by this paper
• Inhibitors of p38 Mitogen-Activated Protein Kinase

  2003cited by this paper
• Novel substituted pyridinyl imidazoles as potent anticytokine agents with low activity against hepatic cytochrome P450 enzymes.

  2003cited by this paper
• Allergen‐induced inflammation and airway epithelial and smooth muscle cell proliferation: role of Jun N‐terminal kinase

  2003influential reference
• ERK, JNK, and p38 MAP kinases differentially regulate proliferation and migration of phenotypically distinct smooth muscle cell subtypes

  2003cited by this paper
• p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases

  2003cited by this paper
• Role of c‐jun N‐terminal kinase in the induced release of GM‐CSF, RANTES and IL‐8 from human airway smooth muscle cells

  2003cited by this paper
• Role of activator protein 1, nuclear factor-kappaB, and nuclear factor of activated T cells in IgE receptor-mediated cytokine expression in mature human mast cells.

  2003cited by this paper
• Role of TCR-Induced Extracellular Signal-Regulated Kinase Activation in the Regulation of Early IL-4 Expression in Naive CD4+ T Cells1

  2003cited by this paper
• Interleukin-1β and Tumor Necrosis Factor-α Induce MUC5AC Overexpression through a Mechanism Involving ERK/p38 Mitogen-activated Protein Kinases-MSK1-CREB Activation in Human Airway Epithelial Cells*

  2003cited by this paper
• Effects of transforming growth factor-[beta] and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells.

  2003cited by this paper
• The burden of asthma with specific reference to the United States.

  2002cited by this paper
• Eotaxin induces migration of RBL-2H3 mast cells via a Rac-ERK-dependent pathway.

  2002cited by this paper
• Regulation of IL‐13 synthesis in human lymphocytes: implications for asthma therapy

  2002cited by this paper
• Adenosine receptor ligands as potential therapeutics in asthma.

  2002cited by this paper
• IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK.

  2002cited by this paper
• The Protein Kinase Complement of the Human Genome

  2002cited by this paper
• Th2 Cytokine Production from Mast Cells Is Directly Induced by Lipopolysaccharide and Distinctly Regulated by c-Jun N-Terminal Kinase and p38 Pathways1

  2002cited by this paper

• LAPTM5 potentiates airway remodeling by regulating MAPKs-mediated airway smooth muscle cells’ dysfunction

  2026cites this paper
• Research advances on epigenetic modifications in dendritic cells in allergic rhinitis

  2025cites this paper
• Anti-asthmatic potential of Rudanti (Capparis moonii Wight): Integrated metabolomics and network pharmacology approach for identifying lead molecule, associated pharmacological mechanisms, and ex-vivo experimental studies

  2025cites this paper
• Disruption of the Clock Component BMAL1 in HDM-induced Asthma Causes GC Resistance in Airway Epithelial Cells by Regulating GR Phosphorylation through the DUSP4-p38MAPK Pathway

  2025cites this paper
• PI3K pathway activation in severe asthma is linked to steroid insensitivity and adverse outcomes

  2025cites this paper
• Oxidative stress in asthma pathogenesis: mechanistic insights and implications for airway smooth muscle dysfunction

  2025cites this paper
• Molecular Study from the Signaling Pathways of Four Potential asthma triggers: AKT1, MAPK13, STAT1, and TLR4

  2025cites this paper
• Demethylzeylasteral (T-96) Alleviates Allergic Asthma via Inhibiting MAPK/ERK and NF-κB Pathway

  2024cites this paper
• Spatiotemporal Clusters of ERK Activity Coordinate Cytokine-induced Inflammatory Responses in Human Airway Epithelial Cells

  2024cites this paper
• Observational study on the potential mechanism of Sanao decoction in the treatment of asthma based on network pharmacology and molecular docking

  2024cites this paper
• The Role of Flavonoids from Aurantii Fructus Immaturus in the Alleviation of Allergic Asthma: Theoretical and Practical Insights

  2024cites this paper
• Spatiotemporal Clusters of Extracellular Signal-Regulated Kinase Activity Coordinate Cytokine-induced Inflammatory Responses in Human Airway Epithelial Cells

  2024cites this paper
• Combining Network Pharmacology and Transcriptomics to Investigate the Mechanisms of Yujiang Paidu Decoction in the Treatment of Chronic Rhinosinusitis with Nasal Polyps

  2024cites this paper
• The interplay of p38 MAPK signaling and mitochondrial metabolism, a dynamic target in cancer and pathological contexts.

  2024cites this paper
• TLR2-ERK signaling pathway regulates expression of galectin-3 in a murine model of OVA-induced allergic airway inflammation.

  2024cites this paper
• Green tea extract suppresses airway inflammation via oxidative stress-driven MAPKs/MMP-9 signaling in asthmatic mice and human airway epithelial cells

  2024cites this paper
• Ceramide Nanoliposomes as Potential Therapeutic Reagents for Asthma

  2023cites this paper
• MAPK1 knockdown ameliorated immune and inflammatory abnormalities in a mouse model of refractory asthma

  2023cites this paper
• Bergapten ameliorates combined allergic rhinitis and asthma syndrome after PM2.5 exposure by balancing Treg/Th17 expression and suppressing STAT3 and MAPK activation in a mouse model.

  2023cites this paper
• The Role of Macrophage Autophagy in Asthma: A Novel Therapeutic Strategy

  2023cites this paper
• An Integrated Analysis Reveals Ciliary Abnormalities in Antrochoanal Polyps

  2023cites this paper
• Luteolin alleviated neutrophilic asthma by inhibiting IL-36γ secretion-mediated MAPK pathways

  2023cites this paper
• Dexmedetomidine represses TGF-β1-induced extracellular matrix production and proliferation of airway smooth muscle cells by inhibiting MAPK signaling pathway.

  2022cites this paper
• Protective Effects of Herba Houttuyniae Aqueous Extract against OVA-Induced Airway Hyperresponsiveness and Inflammation in Asthmatic Mice

  2022cites this paper
• Wogonin attenuates neutrophilic inflammation and airway smooth muscle proliferation through inducing caspase-dependent apoptosis and inhibiting MAPK/Akt signaling in allergic airways.

  2022cites this paper
• Serum dual-specificity phosphatase 1 reflects decreased exacerbation risk, correlates with less advanced exacerbation severity and lower inflammatory cytokines in children with asthma.

  2022cites this paper
• Structural properties and anti-dermatitis effects of flavonoids-loaded gold nanoparticles prepared by Eupatorium japonicum

  2022cites this paper
• TMT-Based Quantitative Proteomic Analysis Reveals Downregulation of ITGAL and Syk by the Effects of Cycloastragenol in OVA-Induced Asthmatic Mice

  2022cites this paper
• Biologically Synthesized Rosa rugosa-Based Gold Nanoparticles Suppress Skin Inflammatory Responses via MAPK and NF-κB Signaling Pathway in TNF-α/IFN-γ-Induced HaCaT Keratinocytes

  2022cites this paper
• Safety and efficacy of p38 mitogen-activated protein kinase inhibitors (MAPKIs) in COPD

  2022cites this paper
• Identification of potential biomarkers and pathogenesis in neutrophil-predominant severe asthma: A comprehensive bioinformatics analysis

  2022cites this paper
• Zeaxanthin attenuates OVA-induced allergic asthma in mice by regulating the p38 MAPK/β-catenin signaling pathway.

  2022cites this paper
• Anti-inflammatory activities of Qingfei oral liquid and its influence on respiratory microbiota in mice with ovalbumin-induced asthma

  2022cites this paper
• Androgen receptor suppresses inflammatory response of airway epithelial cells in allergic asthma through MAPK1 and MAPK14

  2022cites this paper
• An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthma

  2022cites this paper
• Inhibition of Spleen Tyrosine Kinase Restores Glucocorticoid Sensitivity to Improve Steroid-Resistant Asthma

  2022cites this paper
• Sulforaphane inhibits cytokine-stimulated chemokine and adhesion molecule expressions in human corneal fibroblasts: Involvement of the MAPK, STAT, and NF-κB signaling pathways.

  2022cites this paper
• Pattern recognition receptors in health and diseases

  2021cites this paper
• Vitamin K2 Suppresses Proliferation and Inflammatory Cytokine Production in Mitogen-Activated Lymphocytes of Atopic Dermatitis Patients through the Inhibition of Mitogen-Activated Protein Kinases.

  2021cites this paper
• Role of p38 Mitogen-Activated Protein Kinase in Asthma and COPD: Pathogenic Aspects and Potential Targeted Therapies

  2021cites this paper
• Long-chain non-coding RNA n337374 relieves symptoms of respiratory syncytial virus-induced asthma by inhibiting dendritic cell maturation via the CD86 and the ERK pathway.

  2021cites this paper
• Unburned tobacco cigarette smoke alters rat ultrastructural lung airways and DNA.

  2021cites this paper
• Study on toxicological effect and the mechanism of cadmium in rice and inorganic cadmium on ICR mice.

  2021cites this paper
• Interleukin 9 serum level and single nucleotide polymorphism in patients with asthma

  2021cites this paper
• Transcriptome analysis uncovers the key pathways and candidate genes related to the treatment of Echinococcus granulosus protoscoleces with the repurposed drug pyronaridine

  2021cites this paper
• Psoralen inhibits the inflammatory response and mucus production in allergic rhinitis by inhibiting the activator protein 1 pathway and the downstream expression of cystatin-SN

  2021cites this paper
• Blockade of GITRL/GITR signaling pathway attenuates house dust mite-induced allergic asthma in mice through inhibition of MAPKs and NF-κB signaling.

  2021cites this paper
• The p38 MAPK Inhibitors and Their Role in Inflammatory Diseases

  2021cites this paper
• Contribution of dipeptidyl peptidase 10 to airway dysfunction in patients with NSAID‐exacerbated respiratory disease

  2021cites this paper
• Mitogen‐activated protein kinase signaling in childhood asthma development and environment‐mediated protection

  2021cites this paper
• Glucocorticoid Resistance: Interference between the Glucocorticoid Receptor and the MAPK Signalling Pathways

  2021cites this paper
• Vitamin D and the Immune System

  2021cites this paper
• DAP Inhibits the TNF-α-Induced Inflammatory Response by Modulating the MAPK Signaling Pathway in Synovial Cells

  2021cites this paper
• Mast1 mediates radiation-induced gastric injury via the P38 MAPK pathway.

  2021cites this paper
• Anti-asthmatic effects of Phlomis umbrosa Turczaninow using ovalbumin induced asthma murine model and network pharmacology analysis.

  2021cites this paper
• CpG Oligodeoxynucleotides Attenuate OVA-Induced Allergic Airway Inflammation via Suppressing JNK-Mediated Endoplasmic Reticulum Stress

  2021cites this paper
• Fine Particulate Matter Induces Childhood Asthma Attacks via Extracellular Vesicle‐Packaged Let‐7i‐5p‐Mediated Modulation of the MAPK Signaling Pathway

  2021cites this paper
• Dehydrodieugenol improved lung inflammation in an asthma model by inhibiting the STAT3/SOCS3 and MAPK pathways.

  2020cites this paper
• DEK‐targeting aptamer DTA‐64 attenuates bronchial EMT‐mediated airway remodelling by suppressing TGF‐β1/Smad, MAPK and PI3K signalling pathway in asthma

  2020cites this paper
• Proof of pharmacology of Org 48775‐0, a p38 MAP kinase inhibitor, in healthy volunteers

  2020cites this paper
• Abundance of Non-Polarized Lung Macrophages with Poor Phagocytic Function in Chronic Obstructive Pulmonary Disease (COPD)

  2020cites this paper
• Isorhamnetin attenuates TNF‐α‐induced inflammation, proliferation, and migration in human bronchial epithelial cells via MAPK and NF‐κB pathways

  2020cites this paper
• Lophatherum gracile Brongn. attenuates neutrophilic inflammation through inhibition of JNK and calcium.

  2020cites this paper
• Genome-wide analysis of DNA methylation and gene expression changes in an ovalbumin-induced asthma mouse model

  2020cites this paper
• Effects of p38 MAPK signaling pathway on cognitive function and recovery of neuronal function after hypoxic-ischemic brain injury in newborn rats.

  2020cites this paper
• Pulmonary delivery of a p38 α/β MAP kinase inhibitor: bioanalytical method validation and biodistribution in rat plasma and respiratory tissues.

  2020cites this paper
• Exposure to diisononyl phthalate promotes atopic march by activating of NF-κB and p38 MAPK.

  2020cites this paper
• Clinical relevance of understanding mitogen-activated protein kinases involved in asthma

  2020influential citation
• Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectives

  2020cites this paper
• Quantitative proteomics analysis of the treatment of asthma rats with total flavonoid extract from chamomile

  2020cites this paper
• Design and Synthesis of Novel 1-hydroxy-2,4,5-triaryl Imidazole Derivatives as Anti-cytokine Agents

  2020cites this paper
• Mas Receptor Activation Attenuates Allergic Airway In�ammation via Inhibiting JNK/CCL2-induced Macrophage Recruitment

  2020cites this paper
• Mas Receptor Activation Attenuates Allergic Airway In�ammation via Inhibiting JNK/CCL2-induced Macrophage Recruitment

  2020cites this paper
• DK-1108 exerts anti-inflammatory activity against phorbol 12-myristate 13-acetate-induced inflammation and protective effect against OVA-induced allergic asthma.

  2020cites this paper
• Downregulation of miRNA-451a Promotes the Differentiation of CD4+ T Cells towards Th2 Cells by Upregulating ETS1 in Childhood Asthma

  2020cites this paper
• Mas Receptor Activation Attenuates Allergic Airway In�ammation via Inhibiting JNK/CCL2-induced Macrophage Recruitment

  2020cites this paper
• Mas receptor activation attenuates allergic airway inflammation via inhibiting JNK/CCL2-induced macrophage recruitment.

  2020cites this paper
• Mas Receptor Activation Attenuates Allergic Airway In�ammation via Inhibiting JNK/CCL2-induced Macrophage Recruitment

  2020cites this paper
• Wnt/β-catenin signaling pathway regulates asthma airway remodeling by influencing the expression of c-Myc and cyclin D1 via the p38 MAPK-dependent pathway

  2019cites this paper
• Vitamin D and the Immune System

  2019cites this paper
• [Pathogenesis of steroid-resistant asthma and the influence of vitamin D].

  2019cites this paper
• Chrysophanol attenuates airway inflammation and remodeling through nuclear factor‐kappa B signaling pathway in asthma

  2019cites this paper
• Phosphorylation of Proteins

  2019cites this paper
• Prevention and relaxation effects of Liriope platyphylla on bronchial asthma in vitro model by suppressing the activities of MAPK/NF-κB pathway

  2019cites this paper
• Discovery of new JNK3 inhibitory chemotypes via QSAR-Guided selection of docking-based pharmacophores and comparison with other structure-based pharmacophore modeling methods.

  2019cites this paper
• Anti-inflammatory Property of Galectin-1 in a Murine Model of Allergic Airway Inflammation

  2019cites this paper
• Hydroxysafflor Yellow A Alleviates Ovalbumin-Induced Asthma in a Guinea Pig Model by Attenuateing the Expression of Inflammatory Cytokines and Signal Transduction

  2019cites this paper
• Mucin 1 downregulation impairs the anti‐necroptotic effects of glucocorticoids in human bronchial epithelial cells

  2019cites this paper
• Novel Therapeutic Potential of Mitogen-Activated Protein Kinase Activated Protein Kinase 2 (MK2) in Chronic Airway Inflammatory Disorders.

  2019cites this paper
• Inhibition of MAPK and STAT3-SOCS3 by Sakuranetin Attenuated Chronic Allergic Airway Inflammation in Mice

  2019cites this paper
• Targeting Neutrophils in Severe Asthma via Siglec-9

  2018cites this paper
• Exposure to diisodecyl phthalate exacerbated Th2 and Th17-mediated asthma through aggravating oxidative stress and the activation of p38 MAPK.

  2018cites this paper
• Multifaceted role of IL‐21 in rheumatoid arthritis: Current understanding and future perspectives

  2018cites this paper
• New targets for resolution of airway remodeling in obstructive lung diseases

  2018cites this paper
• Lobeglitazone Attenuates Airway Inflammation and Mucus Hypersecretion in a Murine Model of Ovalbumin-Induced Asthma

  2018cites this paper
• Apoptosis signal-regulating kinase 1 (ASK1) inhibition attenuates human airway smooth muscle growth and migration in chronic obstructive pulmonary disease (COPD)

  2018cites this paper
• PI3K, p38 and JAK/STAT signalling in bronchial tissue from patients with asthma following allergen challenge

  2018cites this paper
• Role of IL‐13Rα2 in modulating IL‐13‐induced MUC5AC and ciliary changes in healthy and CRSwNP mucosa

  2018cites this paper
• Granulocyte Colony-Stimulating Factor (G-CSF) for the Treatment of Spinal Cord Injury

  2017cites this paper
• SRC3 expressed in BMSCs promotes growth and migration of multiple myeloma cells by regulating the expression of Cx43

  2017cites this paper